HY-112615-1mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 1 [CAS 2241019-57-6]
|
|
Cancer-programmed cell death
|
|
HY-112615-10mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 1 [CAS 2241019-57-6]
|
|
Cancer-programmed cell death
|
|
HY-112615-5mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 1 [CAS 2241019-57-6]
|
|
Cancer-programmed cell death
|
|
HY-112616-10mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
HY-112616-100mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
HY-112616-25mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
HY-112616-5mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
HY-112616-50mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
HY-16749A-1g
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
HY-16749A-10g
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
HY-16749A-10mg
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
HY-16749A-2g
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
HY-16749A-20g
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
HY-16749A-200mg
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
HY-16749A-5g
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
HY-16749A-5mg
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
HY-16749A-50mg
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
HY-16749A-500mg
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
HY-16749A-1mL
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-16749-1g
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|
HY-16749-10g
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|
HY-16749-10mg
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|
HY-16749-100mg
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|
HY-16749-2g
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|
HY-16749-20g
|
MedChemexpress LLC
|
Pexidartinib [CAS 1029044-16-3]
|
|
Cancer-Kinase/protease
|
|